ALON LAZARUS

Profile

First Name

: ALON

Middle Name

:

Last Name

: LAZARUS

Related Companies
Titles
Company Name
Related People
DIRECTOR
KEROS THERAPEUTICS, INC.
ZAFRIRA AVNUR, NIMA FARZAN, CARL GORDON, OHAD HAMMER, JULIUS KNOWLES, JENN LACHEY, RAN NUSSBAUM, CLAUDIA ORDONEZ, KEITH REGNANTE, JASBIR SEEHRA, JASBIR S. SEEHRA
DIRECTOR
ONCORUS, INC.
THEODORE ASHBURN, THOMAS CHALBERG, LUKE EVNIN, MARY KAY FENTON, MITCHELL FINER, ROBERT KIRKMAN, JOHN MCCABE, BRIGGS MORRISON, CYRUS MOZAYENI, SPENCER NAM, CHRISTOPHE QUEVA, MARC RECHT, CAMERON WHEELER
DIRECTOR
WEREWOLF THERAPEUTICS, INC.
SAKAE ASANUMA, PATRICK BAEUERLE, DAVID CORDO, DEREK DIROCCO, LUKE EVNIN, DANIEL HICKLIN, BRIGGS MORRISON, ELISE WANG, CHRISTOPH WESTPHAL
DIRECTOR
AURON THERAPEUTICS, INC.
ALEXANDRA CANTLEY, ISAAC CIECHANOVER, ANNA FRENCH, CHRISTOPHER GUIFFRE, JOHN DUNCAN HIGGONS, SERGE MESSERLIAN, BRIGGS DUNCAN MORRISON, PINI ORBACH, VICTORIA RICHON, ERIC SHIOZAKI, KATHARINE YEN
DIRECTOR
BLUEJAY THERAPEUTICS, INC.
WEN CHEN, KETING CHU, DAN ESTES, NANCY HONG, TING JIA, PASCAL KROTEE, JIANQING LI, WILLIAM J. RUTTER, DAJUN YANG
DIRECTOR
REUNION NEUROSCIENCE MANAGEMENT, INC.
ROBERT ALEXANDER, NATHAN BRYSON, MICHAEL EHLERS, ANSBERT GADICKE, ELLEN LUBMAN, GREGORY MAYES, BRIGGS MORRISON, MARK POLLACK, NATALIE SACKS, EDWARD SMITH, MARK THEEUWES
DIRECTOR
ENTACT BIO, INC.
ANNA FRENCH, RICHARD GASTER, PINI ORBACH, VICTORIA RICHON, ANDREW SINCLAIR, OWEN SMITH
DIRECTOR
REUNION NEUROSCIENCE, INC.
ROBERT ALEXANDER, NATHAN BRYSON, MICHAEL EHLERS, ANSBERT GADICKE, ELLEN LUBMAN, GREGORY MAYES, BRIGGS MORRISON, MARK POLLACK, NATALIE SACKS, EDWARD SMITH, MARK THEEUWES
DIRECTOR
CROSSBOW THERAPEUTICS, INC.
SAKAE ASANUMA, CHARLES BAUM, ALEXANDRA CANTLEY, TODD FOLEY, IRENA MELNIKOVA, BRIGGS MORRISON, ALEXANDER NOLTE, GERALDINE PAULUS, DMITRI WIEDERSCHAIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-17 
2025-09-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2025-05-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2024-12-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-18 
2024-05-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-19 
2024-05-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-01 
2024-05-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2024-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-19 
2024-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-12 
2023-10-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-14 
2022-08-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-09 
2022-07-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-14 
2021-01-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-23 
2020-12-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-03 
2020-08-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2020-03-12
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-02 
2019-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2018-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-09-21
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2017-11-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
2016-11-14
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-08-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
2016-08-05
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-04-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15